GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mural Oncology PLC (NAS:MURA) » Definitions » Research & Development

MURA (Mural Oncology) Research & Development : $110.67 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mural Oncology Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Mural Oncology's Research & Development for the three months ended in Dec. 2024 was $28.67 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $110.67 Mil.


Mural Oncology Research & Development Historical Data

The historical data trend for Mural Oncology's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mural Oncology Research & Development Chart

Mural Oncology Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Research & Development
159.82 167.19 165.53 110.67

Mural Oncology Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 42.24 26.87 27.54 27.59 28.67

Mural Oncology Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $110.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mural Oncology  (NAS:MURA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Mural Oncology Research & Development Related Terms

Thank you for viewing the detailed overview of Mural Oncology's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Mural Oncology Business Description

Traded in Other Exchanges
N/A
Address
10 Earlsfort Terrace, Dublin 2, Dublin, IRL, D02 T380
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.